Effectiveness of Doxifluridine (5′-Dfur)/Docetaxel Against Advanced/Recurrent Gastric Cancer Showing Resistance to Various Anticancer Drug Regimens

Gastric Cancer - Germany
doi 10.1007/s101200200040
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Outcome of Chemotherapeutic Regimens Cisplatin and 5-Fluorouracil vs Weekly 5-Fluorouracil in Advanced Gastric Cancer

International Journal of Contemporary Medical Research [IJCMR]
2019English

The Efficacy of Docetaxel and Cisplatin Combination Chemotherapy for the Treatment of Advanced Gastric Cancer After Failing to 5-Fluorouracil Based Chemotherapy

Cancer Research and Treatment
Cancer ResearchOncology
2004English

Long-Term Complete Response in a Case of T4 Advanced Rectal Cancer Following Chemoradiotherapy With 5'-Dfur

Nippon Daicho Komonbyo Gakkai Zasshi
2012English

Docetaxel Versus Paclitaxel Combined With 5-Fu and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials

Cancer Research and Treatment
Cancer ResearchOncology
2009English

Low Expression of Stathmin in Tumor Predicts High Response to Neoadjuvant Chemotherapy With Docetaxel-Containing Regimens in Locally Advanced Breast Cancer

Genetic Testing and Molecular Biomarkers
MedicineGenetics
2012English

Longterm Control of Advanced and Recurrent Gastric Cancer (ARGC) by S-1

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2003English

A Long Term Survivor With Advanced Gastric Cancer Showing Multiple Metachronous Extraperitoneal Metastases

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2000English

Noncoding RNAs in Gastric Cancer: Implications for Drug Resistance

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2020English

Combination Therapy With Docetaxel and S-1 as a First-Line Treatment in Patients With Advanced or Recurrent Gastric Cancer: A Retrospective Analysis

World Journal of Surgical Oncology
SurgeryOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy